Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - Revision: v3.3.4 updated from v3.3.3. No functional changes are indicated.
    Difference
    0.0%
    Check dated 2026-01-14T02:23:17.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing Arizona, Florida, Kentucky, Massachusetts, Michigan, Missouri, New York, Ohio, Pennsylvania, Texas, Wisconsin, Alberta, and Quebec; removed the prior individual location subsections; version updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:14:50.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision history update: added Revision v3.3.2 and removed Revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T16:58:45.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page; trial details, contacts, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T15:00:48.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected on the page. The study overview and key sections remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T01:31:51.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. If no other substantive content changed, this is a minor but status/reliability-related update.
    Difference
    2%
    Check dated 2025-10-05T10:34:31.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.